Good morning, everyone, and welcome to the middle of the week. Congratulations on making it this far, and remember, there are only a few more days until the weekend arrives. So keep plugging away. Besides, what else is there to do? While you ponder the possibilities, we invite you to join us for a delightful cup of stimulation. Remember that no prescription is required. Meanwhile, here is the latest menu of tidbits to help you on your way. Have a wonderful day, and please do stay in touch. …

The Food and Drug Administration authorized emergency use of two decades-old malaria drugs for treating Covid-19 in March based on threadbare evidence, according to an agency review obtained by BuzzFeed News. The review referred to only two studies of chloroquine and hydroxychloroquine, which either showed negligible results or have since been called into question altogether. The review also raised serious questions about shoddy practices at overseas factories that manufactured and donated the drugs for use in American hospitals.

Unlock this article by subscribing to STAT Plus and enjoy your first 30 days free!

GET STARTED

What is it?

STAT Plus is STAT's premium subscription service for in-depth biotech, pharma, policy, and life science coverage and analysis. Our award-winning team covers news on Wall Street, policy developments in Washington, early science breakthroughs and clinical trial results, and health care disruption in Silicon Valley and beyond.

What's included?

  • Daily reporting and analysis
  • The most comprehensive industry coverage from a powerhouse team of reporters
  • Subscriber-only newsletters
  • Daily newsletters to brief you on the most important industry news of the day
  • STAT+ Conversations
  • Weekly opportunities to engage with our reporters and leading industry experts in live video conversations
  • Exclusive industry events
  • Premium access to subscriber-only networking events around the country
  • The best reporters in the industry
  • The most trusted and well-connected newsroom in the health care industry
  • And much more
  • Exclusive interviews with industry leaders, profiles, and premium tools, like our CRISPR Trackr.
  • In the matter of the GAO post, I suppose Nicholas has to report but they said. However, if he and they read Pharmalot, the disclosures are rather old news – which doesn’t make them any less disturbing, just lacking in shock value.

Comments are closed.

Sign up to receive a free weekly opinions recap from our community of experts.
Privacy Policy